Wang, Y., Cheng, X., Cui, Y., Hou, J., Ji, Y., Sun, Y., . . . Liu, T. (2018). Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: A propensity score matching analysis. BMC Cancer.
Citação norma ChicagoWang, Yan, Xi Cheng, Yue-hong Cui, Jun Hou, Yuan Ji, Yi-hong Sun, Zhen-bin Shen, Feng-lin Liu, and Tian-shu Liu. "Efficacy After Preoperative Capecitabine and Oxaliplatin (XELOX) Versus Docetaxel, Oxaliplatin and S1 (DOS) in Patients With Locally Advanced Gastric Adenocarcinoma: A Propensity Score Matching Analysis." BMC Cancer 2018.
Citação norma MLAWang, Yan, et al. "Efficacy After Preoperative Capecitabine and Oxaliplatin (XELOX) Versus Docetaxel, Oxaliplatin and S1 (DOS) in Patients With Locally Advanced Gastric Adenocarcinoma: A Propensity Score Matching Analysis." BMC Cancer 2018.